Jiangsu Hengrui reported CNY63.63B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Sh Fosun Pharma CNY 49.15B 248.15M Mar/2026
Sh Pharmaceutical CNY 76.4B 615.53M Dec/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Wuxi Apptec CNY 84.77B 4.11B Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026